Klaria acquires Uppsalagruppen and becomes the owner of the patent that protects Klaria’s technology platform
Klaria Pharma Holding AB (publ) (“Klaria”) today acquires Uppsalagruppen Medical AB (“Uppsalagruppen”) and the patent that protects Klaria’s drug delivery technology. To date, Klaria has had a license from Uppsalagruppen to this patent for specific molecules. With this acquisition, Klaria will now own the patent and have full freedom to develop novel drug candidates in the future.The transaction is structured as a share transfer agreement between the owners of Klaria and Uppsalagruppen, whereby all shares in Uppsalagruppen are acquired by Klaria. As consideration, Klaria has agreed to pay